Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 47.56
3.68 %
$ 2.83 B
Market Cap
-13.21
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Twist Bioscience Corporation
| Revenue | 313 M |
| Cost Of Revenue | 180 M |
| Gross Profit | 133 M |
| Operating Expenses | 354 M |
| Operating Income | -221 M |
| Other Expenses | -12.1 M |
| Net Income | -209 M |
Income Statement
Millions
| Sep-2024 | Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | Sep-2018 | Sep-2017 | Sep-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 313.0 | 245.1 | 203.6 | 132.3 | 90.1 | 54.4 | 25.4 | 10.8 | 2.3 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 179.6 | 155.4 | 119.3 | 80.6 | 61.4 | 47.4 | 32.2 | 24.0 | 9.4 |
| Gross Profit | 133.3 | 89.7 | 84.2 | 51.7 | 28.7 | 7.0 | (6.8) | (13.3) | (7.2) |
| OPERATING INCOME | |||||||||
| Operating Expenses | 354.2 | 306.9 | 333.3 | 205.0 | 146.3 | 115.8 | 63.8 | 45.2 | 36.5 |
| Selling, General and Administrative Expenses | 218.4 | 189.7 | 212.9 | 135.9 | 103.3 | 80.1 | 43.5 | 26.1 | 18.3 |
| Research and Development Expenses | 90.9 | 106.9 | 120.3 | 69.1 | 43.0 | 35.7 | 20.3 | 19.2 | 18.2 |
| Operating Income | (220.8) | (217.2) | (249.0) | (153.3) | (117.6) | (108.8) | (70.6) | (58.5) | (43.7) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 29 K | 5 K | 80 K | 0.4 | 0.8 | 1.3 | 1.3 | 0.9 | 0.7 |
| Total Other Income | 12.7 | 13.7 | 6.5 | (1.3) | 0.5 | 1.5 | (0.4) | (0.5) | (0.4) |
| Pre-Tax Income | (208.2) | (203.5) | (228.3) | (154.0) | (139.5) | (107.4) | (71.0) | (59.0) | (44.1) |
| NET INCOME | |||||||||
| Tax Provision | 0.6 | 1.2 | (10.4) | (1.9) | 0.4 | 0.3 | 0.2 | 0.3 | 0.8 |
| Net Income | (208.7) | (204.6) | (217.9) | (152.1) | (139.9) | (107.7) | (71.2) | (59.3) | (44.1) |
| EPS | 3.6 | 3.6 | 4.04 | 3.15 | 3.57 | 3.92 | 2.68 | 3.16 | 2.35 |